| www.bioportfolio.com |
http://www.bioportfolio.com/bulletin_37.htm
May
4th 2004 |
|
|
Sponsor:
|
|
Biotech industry expert Dr. Ron Garren analyzes newsworthy events in the medical marketplace and places them in the context of value to the investor. Through his website, he distributes frequent email alerts to subscribers. An archive
of past alerts, along with a model portfolio of biotech stocks is also available.
http://www.biotechinsight.com/
|
|
|
|
|
In this issue:
1) Growthink Research's 2004 Healthcare Venture Capital Report
2) CANTAB -
World-leading touch screen
cognitive assessment
3) DailyUpdates - breaking publications and news for the
drug development sector
4) Intelligence and information resources on
CNS Diseases
5)
BioWatch - email news alerts on the life science industry
|
|
Growthink Research's 2004
Healthcare Venture Capital Report
|
|
Growthink Research’s
2004 Healthcare Venture Capital Report analyzes and profiles the 470
healthcare companies that raised venture capital in 2003 (representing
$5.8 billion) and more than 525 investors that funded them. All company
and investor profiles include complete contact information.
The report is
organized by 4 key sectors:·
Biotechnology/Pharmaceutical | Diagnostic/Patient
Care | Healthcare Software &
Services | Medical Devices. Pages:
213. Format: PDF Published: 24th April
2004
The Report provides many benefits to
several audiences:
- Early Stage Ventures: unique insight
into the funding market; identification of the best investors to
target; identification of potential partners; critical competitive
intelligence.
- Venture Capitalists: critical
competitive intelligence for decision-making regarding current
portfolio and new investments.
- Mid-Stage and Late-Stage/Fortune 500
Companies: critical competitive intelligence and identification of
potential ventures to invest in, partner with, or acquire.
- Product & Service Providers:
identification of the most promising ventures that could use your
products and services.
http://www.bioportfolio.com/cgi-bin/acatalog/Bioportfolio_Growthink_5.html |
|
CANTAB World-leading touch
screen cognitive assessment
|
|
CANTAB, the
Cambridge Neuropsychological Test Automated Battery, is sensitive to
cognitive changes caused by a wide range of Central Nervous System (CNS)
disorders [see full
list of disorders - see bibliography]
and medication effects [single
dose examples]. CANTAB’s touch screen technology gives rapid and
non-invasive cognitive assessment. [Dowload
pdf brochure] + [description
of test functions]
http://www.bioportfolio.com/cantab/Default.htm
|
|
DailyUpdates - breaking
publications and news
|
|
DailyUpdates
was launched in 2002 by the pharmaceutical analysts LeadDiscovery
and represents the first "newsfeed" that identifies breaking
scientific publications with drug development potential. Using proprietary data
retrieval strategies LeadDiscovery selects daily 1,000 PubMed articles
and press releases. The selected articles and releases are then scanned by an industrial research panel
which judges those articles considered to be of greatest benefit for the drug development
sector. Selected
publications as well as press releases are then listed on DailyUpdates six therapeutic channels
that match core R&D areas;
View examples:
Subscription to this service is
$95.00/year per channel. From the
day of your subscription you will receive daily email bulletins specific to
your selected channel delivering:
-
key journal articles
selected by LeadDiscovery's panel of industrial R&D experts
-
press releases as they are
distributed announcing news on clinical trials, regulatory approvals and
product launches
-
information on new
pharmaceutical reports offering in-depth analysis of your therapeutic
area.
-
To
subscribe - click here!
|
|
Intelligence and knowledge
resources supporting CNS Disease R&D
|
|
BioPortfolio offers its
readers the opportunity to access a wide range of information resources on
CNS diseases - to evaluate review the links below:
CNS Disease R&D News:
Alzheimer
Disease | Central
Nervous System
| Dementia
| Migraine
Pre-defined web
searches covering all CNS Disease conditions: http://www.bioportfolio.co.uk/web/brain.html
Therapeutic Advances
- Focus
on CNS Disease:
http://www.bioportfolio.com/LeadDiscovery/targetcns.htm
Subscribe to CNS
Diseases DailyUpdate:
http://www.bioportfolio.com/leaddiscovery/daily_update_cns.htm
CNS
Diseases Reports:
http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_CNS_Central_Nervous_System_2004.html
- Antidepressants - Sliding SSRI Revenues Inevitable
- Bipolar Disorders - Zyprexa Sets the Mood for Revenue Growth
- Neuropathic Pain - Comparative Overview of Treatment Preferences Across the Seven Major Markets
- Anxiety Disorders - More Than Just a Comorbidity
- Fibromyalgia - Substantial Growth Opportunity for SNRI Antidepressants
- Migraine - Lots of Experience, But Less Expertise
Leading CNS Diseases Companies - Stock prices
http://www.bioportfolio.com/nasdaq/scroll_Neurological.htm
|
|
BioWatch - email news alerts
on the life science industry
|
|
You select the topic and we deliver breaking news direct to your email box!
“Sentrx has been a subscriber to BioPortfolio for more than a year and we are very pleased with the services provided. We receive news items throughout the day to identify companies that may have a need for Sentrx drug safety solutions. Using this information, we have established a direct mail campaign that is proving to be successful at generating leads. All of our press releases are distributed through BioPortfolio, and the service reaches a wide audience at a reasonable price. Any technical issues are quickly resolved in a courteous, professional manner. I highly recommend BioPortfolio.com.” Jill M.
Notte, Director of Marketing, Sentrx
"We have used the BioPortfolio BioWatch News email alert service for two years to track commercial developments in diabetes, oncology and CNS – we will be subscribing for a third year because we find it a user friendly and an excellent vehicle for keeping us aware”. Lester
Salans.
Download the BioWatch
News Email Alert pdf brochure (100 Kb) (100 Kb) and order form!
Read more at: http://www.bioportfolio.com/news_tracking/index.htm
|
|
|
Contact
us:
Editorial and features: peter.barfoot@bioportfolio.com
Subscriber information:
To
subscribe
for
the BioPortfolio Bulletin in HTML, email:
bioportfolio-subscribe-request@peach.ease.lsoft.com
To
unsubscribe, email: bioportfolio-signoff-request@peach.ease.lsoft.com
WITH NO SUBJECT. The system will automatically remove
your email address from the list based on your email
address. If your email has changed please email peter.barfoot@bioportfolio.com
with a list of your email address and we will manually
unsubscribe for you. Thank you for your understanding.
©2004 BioPortfolio Limited |
|
